TKG Huchems
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
TKG Huchems makes specialty chemicals used in industrial manufacturing, including DNT (dinitrotoluene), an intermediate material in producing polyurethane, and a range of nitric-acid-based products derived from ammonia.
Its customers include manufacturers in industries that rely on polyurethane materials and nitrogen-based chemicals. Listed on KOSPI, Korea's main stock exchange, the company earns the large majority of its revenue from these two core product lines, with a smaller share coming from electronic materials, urea solution, and carbon-emission credits generated through greenhouse-gas reduction activities.
Summary is AI-generated and may contain errors · figures from DART filings
TKG Huchems in five facts
What does TKG Huchems do?
TKG Huchems makes specialty chemicals used in industrial manufacturing, including DNT (dinitrotoluene), an intermediate material in producing polyurethane, and a range of nitric-acid-based products derived from ammonia.
Where is TKG Huchems listed and in which sector?
TKG Huchems (Korean name: TKG휴켐스) trades under KRX code 069260 on KOSPI, the main board of the Korea Exchange. It is classified in the Materials sector, Chemicals.
How large is TKG Huchems?
Its market capitalisation was US$471.7M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were TKG Huchems's latest annual revenue and operating profit?
For fiscal year 2025, TKG Huchems reported revenue of US$851.1M, operating profit of US$49.5M and net income of US$44.7M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was down 5.1% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Decision to acquire shares/equity in another company
TKG Huchems disclosed an acquisition, worth US$35.2M.
M&A · Oct 21 - Supply contract terminated
TKG Huchems Co., Ltd.'s DNT sale/purchase agreement with OCI Co., Ltd., running since 2014-08-18, was terminated effective 2027-03-28 after OCI decided to exit its TDI business; the terminated amount of US$218M represents 41.0% of TKG Huchems' most recent annual revenue.
Supply contract · Sep 29 - Supply contract signedSupply contract · Sep 28
- Operating results (consolidated) (preliminary) (fair disclosure)
TKG Huchems filed provisional (unaudited) consolidated results for Q2 2026: revenue of US$279M (+36.9% year on year), operating profit of US$23.1M (+49.2% year on year) and net income of US$15.7M (+23.4% year on year).
Earnings · Aug 7 - [Amended] Decision to acquire shares/equity in another company
TKG Huchems updated the disclosed terms of an acquisition of AprilBio, now worth US$102M.
M&A · Jul 23 - Decision to acquire shares/equity in another company
TKG Huchems disclosed an acquisition of AprilBio, worth US$97M.
M&A · Jun 25 - Operating results (consolidated) (preliminary) (fair disclosure)
TKG Huchems filed provisional (unaudited) consolidated results for Q1 2026: revenue of US$203M (+9.5% year on year), operating profit of US$10.4M (+20.4% year on year) and net income of US$9.16M (−4.6% year on year).
Earnings · May 8 - Results of rights offering or equity-linked bond issuance (voluntary)Capital raise · Apr 23
- Material event report (convertible bonds)
TKG Huchems disclosed convertible bonds to raise US$33.8M, about 7.7% of its market value.
Capital raise · Apr 8 - Cash/in-kind dividend decision
TKG Huchems declared a cash dividend of US$0.69 per share.
Dividend · Feb 11 - Operating results (consolidated) (preliminary) (fair disclosure)
TKG Huchems filed provisional (unaudited) consolidated results for Q4 2025: revenue of US$190M (−11.4% year on year), operating profit of US$3.17M (−43.9% year on year) and a net loss of US$770K (from a profit a year earlier).
Earnings · Feb 11